Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs Prothena Corporation plc (PRTA)

Assembly Biosciences, Inc. and Prothena Corporation plc are both Biotechnology companies. Assembly Biosciences, Inc. and Prothena Corporation plc are of similar size ($421.5M and $405.6M). Prothena Corporation plc grew revenue faster over the last twelve months: 427.3% against 125.1%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −80.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Assembly Biosciences, Inc. leads on 11 and Prothena Corporation plc on 4.

Valuation

Metric ASMB PRTA Biotechnology median
P/E n/m n/m 10.64
P/S 5.04 7.89 9.59
P/B 1.23 1.50 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 0.76 2.60 9.45
Earnings yield (0.80%) (10.06%) (34.69%)
Free cash flow yield (10.23%) (14.13%) (24.02%)

Profitability

Metric ASMB PRTA Biotechnology median
Gross margin 100.00% 100.00% 65.59%
Operating margin (11.75%) (101.80%) 0.00%
Net margin (0.06%) (80.67%) 0.00%
Free cash flow margin (51.53%) (111.49%) 0.00%
Return on equity (0.03%) (14.39%) (51.96%)
Return on assets (0.02%) (12.54%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASMB PRTA Biotechnology median
Revenue growth (TTM) 125.12% 427.32% 4.59%
EPS growth (last fiscal year) 91.78% (99.56%) 29.88%
Revenue growth, 5-year CAGR 35.27% 62.56% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB PRTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.99 25.05 4.86
Net debt to EBITDA 17.31 1.46 1.01

Dividend

Metric ASMB PRTA Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ASMB PRTA Biotechnology median
Market cap 405.59m 421.47m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack